Article
Presented by Randall G. Rowland, MD, University of Kentucky, Lexington.
NDA submitted for 3-month formulation of leuprolide mesylate for advanced prostate cancer
Key updates from the AUA/ASRM male infertility guideline amendment
PSMA PET/CT can reveal prostate cancer recurrences before biochemical criteria met
Speaking of Urology: Dr. Winter on the use of vaginal estrogen
Vaginal estrogen for GSM not associated with major adverse cardiovascular events
FDA approves oral sulopenem for uncomplicated urinary tract infection